Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Phenolamide-driven α-glucosidase inhibitory activity in immature fruits of the Korean landrace-derived chili pepper Sumihyang.

Created on 22 Jul 2026

Authors

Seong-Im Park, Sang Seok Lee, Dae Hong Lee, Hyo Jin Lee, Kil Su Jang

Published in

Plant molecular biology. Volume 116. Issue 4. Jul 22, 2026. Epub Jul 22, 2026.

Abstract

Understanding the biochemical basis of α-glucosidase inhibitory (AGI) activity in chili peppers (Capsicum annuum L.) is essential for their development as functional food ingredients. This study evaluated AGI activity and phytochemical profiles across four ripening stages in three C. annuum cultivars: Sumihyang (a cultivar derived from the Korean landrace Subicho), Dangjo (a functional antidiabetic cultivar), and Olbokhap (a disease-resistant commercial cultivar). Enzyme assays revealed that AGI activity peaked at the immature stage in all cultivars, with Sumihyang consistently exhibiting the highest activity across two harvest periods. Untargeted metabolomic profiling at the immature and turning stages identified two phenolamides, caffeoylputrescine and feruloylputrescine, that were selectively enriched in immature Sumihyang and strongly correlated with AGI activity (r > 0.92). While the AGI effect of caffeoylputrescine has been previously reported, feruloylputrescine was evaluated here for the first time under this assay system. In vitro validation confirmed their inhibitory activities, with half maximal inhibitory concentration (IC50) values of 193 µM for caffeoylputrescine and 291 µM for feruloylputrescine. These findings suggest that phenolamide composition, rather than total flavonoid content, is a key determinant of AGI activity in chili peppers. The selective accumulation of these phenolamides in immature Sumihyang highlights its potential as a genetic resource for developing antidiabetic functional foods.

PMID:
42484719
Bibliographic data and abstract were imported from PubMed on 22 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement